{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:57Z","timestamp":1761541197575},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Heart Lung and Blood Institute of National Institutes of Health","award":["R01 HL062136"],"award-info":[{"award-number":["R01 HL062136"]}]}],"content-domain":{"domain":["tmreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.tmrv.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T08:25:15Z","timestamp":1409905515000},"page":"187-197","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome"],"prefix":"10.1016","volume":"28","author":[{"given":"Han-Mou","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2014.08.004_bb0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197505222922102","article-title":"Hemolytic uremic syndrome in families","volume":"292","author":"Kaplan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0010","series-title":"Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","first-page":"163","article-title":"Atypical hemolytic uremic syndrome","author":"Fitzpatrick","year":"1992"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0015","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.hoc.2013.02.006","article-title":"Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update","volume":"27","author":"Tsai","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0030","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0609.2003.00026.x","article-title":"Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura","volume":"70","author":"Tsai","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0040","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0950-3536(98)80064-4","article-title":"Deficiency of von Willebrand factor\u2013cleaving protease in familial and acquired thrombotic thrombocytopenic purpura","volume":"11","author":"Furlan","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-003-1382-z","article-title":"Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia","volume":"19","author":"Cochran","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2007.03.055","article-title":"Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience","volume":"151","author":"Waters","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0080","doi-asserted-by":"crossref","first-page":"e40589","DOI":"10.1371\/journal.pone.0040589","article-title":"Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus","volume":"7","author":"Veron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0095","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00467-002-0895-1","article-title":"Cobalamin C deficiency complicated by an atypical glomerulopathy","volume":"17","author":"Brunelli","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2013.08.031","article-title":"Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency","volume":"63","author":"Cornec-Le","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1160\/TH10-04-0216","article-title":"Identification of three novel plasminogen (PLG) gene mutations in a series of 23 patients with low PLG activity","volume":"105","author":"Klammt","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2516.2008.01825.x","article-title":"Plasminogen deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0120","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0130","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of factor I\u2013associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jmg.2005.030783","article-title":"The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts","volume":"42","author":"Fremeaux-Bacchi","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0150","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molimm.2011.11.003","article-title":"Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS","volume":"49","author":"Ermini","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0160","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0165","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02274831","article-title":"Measurement of complement activation products in patients with chronic rheumatic diseases","volume":"10","author":"Auda","year":"1990","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clin.1995.1040","article-title":"The value of complement activation products in the assessment of systemic lupus erythematosus flares","volume":"74","author":"Porcel","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0190","first-page":"250","article-title":"Terminal complement complexes and C1\/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions","volume":"84","author":"Oleesky","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0195","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant\u2013associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","article-title":"Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"24","author":"Iacopino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0210","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","article-title":"Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion","volume":"78","author":"Hahn","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aji.12000","article-title":"Complement in pregnancy: a delicate balance","volume":"69","author":"Denny","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0220","first-page":"46","article-title":"Complement activation in relation to development of preeclampsia","volume":"78","author":"Haeger","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0225","first-page":"698","article-title":"Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"76","author":"Haeger","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0230","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0240","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MNH.0b013e328365b3fe","article-title":"Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"22","author":"Noris","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0245","series-title":"ADAMTS13: biology and disease, chapter 7","article-title":"Acquired thrombotic thrombocytopenic purpura","author":"Tsai","year":"2014"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.semnephrol.2010.06.006","article-title":"Genetics and genetic testing in hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura","volume":"30","author":"Noris","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0255","series-title":"Wintrobe's clinical hematology, 13\/e, Chapter 48","article-title":"Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome and related disorders","author":"Tsai","year":"2013"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0260","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/rheumatology\/kel176","article-title":"Deficient activity of von Willebrand factor\u2013cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's disease","volume":"45","author":"Hirata","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0265","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09084.x","article-title":"Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura","volume":"157","author":"Chapin","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2014.08.004_bb0270","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bjh.12387","article-title":"Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up","volume":"162","author":"Tsai","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796314000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796314000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T03:22:49Z","timestamp":1538277769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796314000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0887796314000704"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2014.08.004","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}